Divi’s Labs shares plunge around 9 per cent on back of weak operational performance – know what brokerages say
Pharmaceutical major Divi's Laboratories shares tumbled around 9 per cent to Rs 4,751 per share on the BSE intraday trade on Monday on the back of weak operational performance in the second quarter of the financial year 2021-22 (Q2FY21).
The global brokerage firm said margin came off but remained buoyant at 41 per cent: PTI